State of the art. Autologous fat graft and adipose tissue-derived stromal vascular fraction injection for hand therapy in systemic sclerosis patients

Current Research in Translational Medicine

Volumn 64, Issue 1, 2016, Pages 35-42

  Guillaume Jugnot, P ^a   Daumas, A ^b   Magalon, J ^c   Sautereau, N ^a   Veran, J ^c   Magalon, G ^c   Sabatier, F ^c,d   Granel, B ^a,d  

^a HÔPITAL NORD   (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Adipose tissue; Cell therapy; Regenerative medicine; Stromal vascular fraction; Systemic sclerosis

Indexed keywords

VASODILATOR AGENT; CYTOKINE; SIGNAL PEPTIDE;

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; ADIPOSE TISSUE DERIVED STROMAL VASCULAR FRACTION CELL; ADULT STEM CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOGRAFT; ENDOTHELIUM CELL; HAND DISEASE; HEMATOPOIETIC CELL; HUMAN; HYGIENE; IMMUNOMODULATION; PERICYTE; PHYSIOTHERAPY; QUALITY OF LIFE; SAFETY; STEM CELL TRANSPLANTATION; STROMA; SYSTEMIC SCLEROSIS; TISSUE REGENERATION; AUTOTRANSPLANTATION; BLOOD CELL; CLINICAL TRIAL (TOPIC); COMPLICATION; HAND MALFORMATION; INJECTION; LIPECTOMY; MACROPHAGE; MESENCHYMAL STEM CELL TRANSPLANTATION; SECRETION (PROCESS); STROMA CELL; TRANSPLANTATION; TREATMENT OUTCOME;

ADIPOSE TISSUE; ADULT STEM CELLS; BLOOD CELLS; CLINICAL TRIALS AS TOPIC; CYTOKINES; ENDOTHELIAL CELLS; HAND DEFORMITIES, ACQUIRED; HUMANS; INJECTIONS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPECTOMY; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; PERICYTES; SCLERODERMA, SYSTEMIC; STROMAL CELLS; TISSUE AND ORGAN HARVESTING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84978174686     PISSN: None     EISSN: 24523186     Source Type: Journal    
DOI: 10.1016/j.retram.2016.01.006     Document Type: Article

References (49)

1. Mouthon L., Carpentier P.H., Lok C., Clerson P., Gressin V., Hachulla E., et al. Ischemic digital ulcers affect hand disability and pain in systemic sclerosis. J Rheumatol 2014, 41(7):1317-1323.
2. Guillevin L., Hunsche E., Denton C.P., Krieg T., Schwierin B., Rosenberg D., et al. Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. Clin Exp Rheumatol 2013, 31(2 Suppl. 76):71-80.
3. Rannou F., Poiraudeau S., Berezné A., Baubet T., Le-Guern V., Cabane J., et al. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. Arthritis Rheum 2007, 57(1):94-102.
4. van Laar J.M., Farge D., Sont J.K., Naraghi K., Marjanovic Z., Larghero J., et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 2014, 311(24):2490-2498.
5. Farge D., Marolleau J.P., Zohar S., Marjanovic Z., Cabane J., Mounier N., et al. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study. Br J Haematol 2002, 119(3):726-739.
6. Keyszer G., Christopeit M., Fick S., Schendel M., Taute B.M., Behre G., et al. Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases. Arthritis Rheum 2011, 63(8):2540-2542.
7. Coleman S.R. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg 2006, 118(3 Suppl.):108S-120S.
8. Zuk P. Adipose-derived stem cells in tissue regeneration: a review. Int Sch Res 2013, e713959.
9. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 2007, 100(9):1249-1260.
10. Bourin P., Bunnell B.A., Casteilla L., Dominici M., Katz A.J., March K.L., et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 2013, 15(6):641-648.
11. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7(2):211-228.
12. ®) System: automated processing of adipose-derived regenerative cells in a functionally closed system. Adv Wound Care 2014, 3(1):38-45.
13. Zhu X., Shi W., Tai W., Liu F. The comparition of biological characteristics and multilineage differentiation of bone marrow and adipose derived mesenchymal stem cells. Cell Tissue Res 2012, 350(2):277-287.
14. Ong W.K., Sugii S. Adipose-derived stem cells: fatty potentials for therapy. Int J Biochem Cell Biol 2013, 45(6):1083-1086.
15. Strong A.L., Cederna P.S., Rubin J.P., Coleman S.R., Levi B. The current state of fat grafting: a review of harvesting, processing, and injection techniques. Plast Reconstr Surg 2015, 136(4):897-912.
16. Iyyanki T., Hubenak J., Liu J., Chang E.I., Beahm E.K., Zhang Q. Harvesting technique affects adipose-derived stem cell yield. Aesthetic Surg J Am Soc Aesthetic Plast Surg 2015, 35(4):467-476.
17. Alharbi Z., Opländer C., Almakadi S., Fritz A., Vogt M., Pallua N. Conventional vs. micro-fat harvesting: how fat harvesting technique affects tissue-engineering approaches using adipose tissue-derived stem/stromal cells. J Plast Reconstr Aesthetic Surg 2013, 66(9):1271-1278.
18. Granel B., Daumas A., Jouve E., Harlé J.-R., Nguyen P.-S., Chabannon C., et al. Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis 2014, 81:2056. [annrheumdis 2014].
19. Vanneaux V., Farge-Bancel D., Lecourt S., Baraut J., Cras A., Jean-Louis F., et al. Expression of transforming growth factor β receptor II in mesenchymal stem cells from systemic sclerosis patients. BMJ Open 2013, 3(1).
20. Avouac J., Juin F., Wipff J., Couraud P.O., Chiocchia G., Kahan A., et al. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann Rheum Dis 2008, 67(10):1455-1460.
21. Harada Y., Yamamoto Y., Tsujimoto S., Matsugami H., Yoshida A., Hisatome I. Transplantation of freshly isolated adipose tissue-derived regenerative cells enhances angiogenesis in a murine model of hind limb ischemia. Biomed Res Tokyo Jpn 2013, 34(1):23-29.
22. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8(4):315-317.
23. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005, 7(5):393-395.
24. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109(10):1292-1298.
25. Nakagami H., Maeda K., Morishita R., Iguchi S., Nishikawa T., Takami Y., et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol 2005, 25(12):2542-2547.
26. Planat-Benard V., Silvestre J.-S., Cousin B., André M., Nibbelink M., Tamarat R., et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004, 109(5):656-663.
27. Leto Barone A.A., Khalifian S., Lee W.P.A., Brandacher G. Immunomodulatory effects of adipose-derived stem cells: fact or fiction?. BioMed Res Int 2013, 3836-3885.
28. Cui L., Yin S., Liu W., Li N., Zhang W., Cao Y. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 2007, 13(6):1185-1195.
29. Puissant B., Barreau C., Bourin P., Clavel C., Corre J., Bousquet C., et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005, 129(1):118-129.
30. McIntosh K., Zvonic S., Garrett S., Mitchell J.B., Floyd Z.E., Hammill L., et al. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 2006, 24(5):1246-1253.
31. DelaRosa O., Lombardo E., Beraza A., Mancheño-Corvo P., Ramirez C., Menta R., et al. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng Part A 2009, 15(10):2795-2806.
32. Cho K.-S., Park M.-K., Kang S.-A., Park H.-Y., Hong S.-L., Park H.-K., et al. Adipose-derived stem cells ameliorate allergic airway inflammation by inducing regulatory T cells in a mouse model of asthma. Mediators Inflamm 2014, 436476.
33. Peng W., Gao T., Yang Z.-L., Zhang S.-C., Ren M.-L., Wang Z.-G., et al. Adipose-derived stem cells induced dendritic cells undergo tolerance and inhibit Th1 polarization. Cell Immunol 2012, 278(1-2):152-157.
34. Clark R.A.F. Synergistic signaling from extracellular matrix-growth factor complexes. J Invest Dermatol 2008, 128(6):1354-1355.
35. Szöke K., Beckstrøm K.J., Brinchmann J.E. Human adipose tissue as a source of cells with angiogenic potential. Cell Transplant 2012, 21(1):235-250.
36. Wosnitza M., Hemmrich K., Groger A., Gräber S., Pallua N. Plasticity of human adipose stem cells to perform adipogenic and endothelial differentiation. Differ Res Biol Divers 2007, 75(1):12-23.
37. Díaz-Flores L., Gutiérrez R., Madrid J.F., Varela H., Valladares F., Acosta E., et al. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 2009, 24(7):909-969.
38. Tallone T., Realini C., Böhmler A., Kornfeld C., Vassalli G., Moccetti T., et al. Adult human adipose tissue contains several types of multipotent cells. J Cardiovasc Transl Res 2011, 4(2):200-210.
39. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009, 15(8):930-939.
40. Navarro A., Marín S., Riol N., Carbonell-Uberos F., Miñana M.D. Human adipose tissue-resident monocytes exhibit an endothelial-like phenotype and display angiogenic properties. Stem Cell Res Ther 2014, 5(2):50.
41. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007, 117(1):175-184.
42. Lynch L., Nowak M., Varghese B., Clark J., Hogan A.E., Toxavidis V., et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 2012, 37(3):574-587.
43. Spits H., Artis D., Colonna M., Diefenbach A., Di Santo J.P., Eberl G., et al. Innate lymphoid cells - a proposal for uniform nomenclature. Nat Rev Immunol 2013, 13(2):145-149.
44. Molofsky A.B., Nussbaum J.C., Liang H.-E., Van Dyken S.J., Cheng L.E., Mohapatra A., et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med 2013, 210(3):535-549.
45. Caspar-Bauguil S., Cousin B., Bour S., Casteilla L., Castiella L., Penicaud L., et al. Adipose tissue lymphocytes: types and roles. J Physiol Biochem 2009, 65(4):423-436.
46. Bank J., Fuller S.M., Henry G.I., Zachary L.S. Fat grafting to the hand in patients with Raynaud phenomenon: a novel therapeutic modality. Plast Reconstr Surg 2014, 133(5):1109-1118.
47. Del Papa N., Di Luca G., Sambataro D., Zaccara E., Maglione W., Gabrielli A., et al. Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis. Cell Transplant 2015, 24(11):2297-2305.
48. Guillaume-Jugnot P., Daumas A., Magalon J., Jouve E., Nguyen P.-S., Truillet R., et al. Autologous adipose-derived stromal vascular fraction in patients with systemic sclerosis: 12-month follow-up. Rheumatology 2016, 55(2):301-306.
49. Georges C., Chassany O., Mouthon L., Tiev K., Toledano C., Meyer O., et al. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 2005, 24(1):3-10.